Navigation Links
Comparision of overall survival for non-small cell lung cancer patients
Date:5/28/2010

CHICAGO, IL. (May 28, 2010)There's debate about the best treatment approach for patients with certain stages of non-small cell lung cancer (NSCLC), which accounts for about 80 percent of all lung cancers. Patients with early stages of NSCLC are typically treated with surgery, but those with stage IIIA present more of a challenge because they are such a diverse group. However, research from Fox Chase Cancer Center shows that patient's with stage IIIA NSCLC who receive surgery, lobectomy in particular, have increased overall survival compared to those who received chemoradiation alonethose receiving lobectomy plus chemoradation had survival rates that were higher than previously reported as well.

The research, led by Charu Aggarwal, M.D., M.P.H., Walter Scott, M.D., F.A.C.S., and George Simon, M.D., will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology on Sunday June 6.

Stage IIIA presents challenges because patients classified at that level are such a diverse group. The common denominator is that cancer has spread to lymph nodes on the same side of the chest as the primary tumor, but beyond that, stage IIIA patients may have tumors of any size and may differ in the number and location of affected lymph nodes.

"In the past, patients with advanced stage lung cancer were treated either with surgery alone, chemotherapy alone, or radiation alone," says Aggarwal. "Scientists and clinicians found that adding radiation to chemotherapy improved survival, so concurrent chemotherapy and radiation together became the standard of care." Recent large, Phase III clinical trials showed that patients treated with chemoradiation followed by surgery were more likely to be disease-free than counterparts who received chemoradiation without surgery set the stage for Aggarwal's study.

Looking at data from 249 patients treated at Fox Chase for stage IIIA non-small cell lung cancer from 2000 through 2008, the research team divided patients into three groups based on the treatments they received: chemoradiation only, chemoradiation plus surgical removal of a lung (pneumonectomy), or chemoradiation plus surgical removal of only one lobe of the lung (lobectomy).

Biostatistician Brian Egleston, Ph.D., used a technique called propensity score analysis to balance the three groups in terms of age, gender, smoking status, physical condition, and other variables that could bias the results.

"After we adjusted for all those variables, we saw that patients who received surgery, lobectomy in particular, had increased overall survival compared to those who received chemoradiation alone," says Aggarwal. "We saw overall survival of 40 percent at five years for chemoradiation plus lobectomy, higher than seen with pneumonectomy."

Removing the entire lung, a more extensive procedure that poses a greater risk of post-operative complications, offered no additional survival benefit." This tells us that you don't have to put the patient through pneumonectomy; you might get superior outcomes with a smaller, safer operation," says Aggarwal, who received an ASCO Foundation Merit Award for this research.


'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Related medicine news :

1. Study shows modest improvement in advanced lung cancer overall survival rates
2. 3M Recognized for Overall Software Performance in KLAS Industry Survey
3. Research validates surgery alone offers reasonable overall survival for stage I SCLC
4. News brief: ALDH associated with worse overall survival in patients with pancreatic adenocarcinoma
5. Survey: Toyota owners maintain high overall satisfaction despite recalls
6. UCSF Tops Public Institutions in NIH Funding, Ranks Second Overall
7. DBLG Announces Release 1.0 of the HITECH Act Survival Guide: an Open Source Law Initiative
8. Intensive Insulin Therapy Wont Boost Septic Shock Survival
9. Vitamin D Linked to Survival in Lymphoma Patients
10. Sonic Hedgehog variations linked to recurrence, survival and response to therapy of bladder cancer
11. Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Bethesda, MD (PRWEB) , ... May 03, 2016 , ... ... new line of reusable bags to replace billions of single-use, throw away plastic baggies. ... waste devastating our oceans and sea life. , “The LunchSkins mission is ...
(Date:5/3/2016)... ... May 03, 2016 , ... Dave Newberry, broker/owner of Newberry Realty, recently announced ... annual fundraiser luncheon on Friday, May 20. “We have raised over $1,000 for the ... abuse,” said Newberry. , PICC is a local Kent, WA, clinic that cares for ...
(Date:5/3/2016)... ... 2016 , ... The American Medical Informatics Association (AMIA) responded ... National Coordinator for Health IT (ONC) with qualified support for officials to conduct ... terminating certifications issued to Complete EHRs and Health IT Modules. The organization of ...
(Date:5/2/2016)... ... May 02, 2016 , ... It has just been announced ... for five events throughout the month of May. , Uldrich is the author of ... outlets. He also frequently appears on the Science Channel’s FutureScape and Discovery Channel’s Inside ...
(Date:5/2/2016)... ... May 02, 2016 , ... ProElectric Cartoon is a ... X. Pick and choose from a variety of electric styles including zap, sizzles, and ... can customize shadow, dof blur, three dimensional rotation, and much more. ProElectric Cartoon’s simplistic ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- Research and Markets has announced the ... 2016-2020" report to their offering.      ... global plastic surgery products market is expected to grow ... , ,The growing adoption of laser in aesthetics is ... market. Lasers are used to treat a broad range ...
(Date:4/28/2016)... 2016 Treato , the ... announced today that it has been named a Cool ... in Life Sciences, 2016, Stephen Davies , ... focuses on life-science- oriented analytics, algorithms and smart machine ... doctors, confirm medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
Breaking Medicine Technology: